首页> 美国卫生研究院文献>Allergy Asthma Immunology Research >A Comprehensive Review of the Treatment of Atopic Eczema
【2h】

A Comprehensive Review of the Treatment of Atopic Eczema

机译:特应性湿疹的治疗综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Atopic eczema (AE) is a chronic, inflammatory skin disorder which usually develops in early childhood. In spite of intensive investigations, the causes of AE remain unclear, but are likely to be multifactorial in nature. Environmental factors or genetic-environmental interactions seem to play a key role in disease progression. Among various measures of AE managment, cutaneous hydration, which improves barrier function and relieve itchiness, may be helpful to reduce the need for topical steroid use and therefore should be used as a basic treatment. Avoiding aggravating factors is also a basic treatment of AE. Standard medical treatment with a pharmacologic approach may be necessary if basic treatment fails to control symptoms satisfactorily. Recently, more attention is given to a proactive therapeutic by regular intermittent application of low potency steroids or topical calcineurin inhibitors to prevent new flares. Furthermore, various targeted biologics are being introduced for AE control and are proposed as promising therapies. This paper provides a summary of the recent literature on the manangement of AE and a treatment guideline.
机译:特应性湿疹(AE)是一种慢性炎症性皮肤病,通常在儿童早期发展。尽管进行了深入研究,但AE的原因仍不清楚,但本质上可能是多因素的。环境因素或遗传-环境相互作用似乎在疾病进展中起关键作用。在AE管理的各种措施中,可改善屏障功能并缓解瘙痒的皮肤水合作用可能有助于减少局部使用类固醇的需要,因此应作为基本治疗方法。避免加重因素也是AE的基本治疗方法。如果基本治疗不能令人满意地控制症状,则可能需要采用药理学方法进行标准医学治疗。最近,通过定期间歇性应用低效类固醇或局部钙调神经磷酸酶抑制剂来预防新的耀斑,人们对主动治疗有了更多的关注。此外,各种靶向生物制剂被引入用于AE控制,并且被提议作为有前途的疗法。本文提供了有关AE管理的最新文献摘要和治疗指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号